JETRO AnnouncementsApply Now: Regenerative medicine companies for Japan Entry Acceleration Program 2026

Jul 01, 2026

JEAP, short for the Japan Entry Acceleration Program, is built on the idea of turning bold visions into real opportunities. The program represents creativity without limits, fresh beginnings in Japan, and the energy to connect globally and grow faster.

With this spirit at its core, JEAP invites pioneering companies in regenerative medicine to join us in shaping the future of healthcare in Japan.

As part of JEAP, selected companies gain access to Japan’s business ecosystem, from tailored mentorship and market insights to direct connections with leading CDMOs/CROs and Pharmaceutical companies.

With the support of Forum for Innovative Regenerative Medicine (FIRM) this year, we will provide comprehensive support needed to accelerate market entry, collaboration, and growth in one of the world’s most advanced markets.

Logo of the Japan Entry Acceleration Program (JEAP) with [Powered by Invest Japan J-Bridge] at the bottom.

Organized by

Logo of Japan External Trade Orgnization (JETRO) as an organizer

Supported by

Logo of Forum for Innovative Regenerative Medicine (FIRM) as a supporter

CONTENTS

The schedule of the regenerative medicine acceleration program is as follows: From July to October 2026, the call for applications and selection process for regenerative medicine companies will be conducted. From November to February, online workshops, mentoring sessions, and meetings with Japanese companies will be held. In mid-February 2027, an on-site Demo Day will take place in Tokyo.

Outline
Program Name Japan Entry Acceleration Program 2026
Program Period November 1 2026- February 20 2027 (TBD)
Application Period July 1 2026 - October 16 2026* (TBD)
Applications submitted by Aug 16 will be reviewed first, with at least 5 companies selected in this phase.
Subsequent applications (Aug 17 onward) will be considered for the remaining slots.
The application window may close early once the cohort reaches approximately 10 companies.
For more details on the selection process, see the program brochure above.
Capacity Approx. 10 companies
Location The program will be held mainly online, with Site Visits & Demo Day taking place in person in Tokyo and Osaka.
Eligibilities
  1. 1.

    Field of Focus

    • Regenerative Medicine
    • Cell Therapy
    • Gene Therapy
    • Tissue Engineering (including Scaffolds)
    • ATMPs (Advanced Therapy Medicinal Products)
    • Cell & Gene Therapy Products
  2. 2.

    Development Stage

    Companies with identified clinical development candidates

  3. 3.

    Interest in Entering the Japanese Market

    Companies that are considering business expansion into Japan or have a concrete interest in the Japanese market.

  4. 4.

    Commitment to Participate in the Program

    Companies are required to commit to participating in multiple sessions of the program, including the Demo Day to be held in Japan in February 2027.

Selection Schedule Screening will be conducted on a rolling basis, beginning as soon as applications open. Results will be communicated to all applicants by October 16. We appreciate your patience during this time. For more information on the selection process, please refer to the program brochure above.
Program Content
  1. 1.

    Workshop & Mentoring (Online, November 2026–February 2027)

    • Expert-led workshop and 1-on-1 mentoring on Japan’s market, regulations, reimbursement, R&D and clinical develop environment, business strategy
  2. 2.

    Business Networking (Hybrid, December 2026–February 2027)

    • Connect with the right partners across Japan’s healthcare ecosystem.
    • Access Japan’s R&D and clinical ecosystem (KOLs, research institutions, and more).
    • Engage with PMDA and regulatory experts.
    • Meet corporates, CDMOs, and CROs.
  3. 3.

    Site Visit and Demo Day in Japan (On-site, mid-February 2027; exact dates TBD)

    • Pitch opportunities with investors and potential partners in Japan, enhancing visibility and enabling face-to-face relationship building
Participation fee Free of charge.
Note:
  • Participants may extend their stay before and/or after the ”Site Visit and Demo Day” period for up to the same number of days as that period. The "Site Visit and Demo Day" is scheduled to take place around mid-February, and the exact dates and duration will be finalized after the selection of participants in mid-October.
  • JETRO will cover one round-trip economy class airfare per participant.
  • Accommodation expenses will be covered only for the official "Site Visit and Demo Day" period and only for the hotel(s) designated and arranged by JETRO. Participants are responsible for arranging and covering any accommodation outside the program period. Expenses for accompanying persons will not be covered.
Organizer JETRO
Supporter Forum for Innovative Regenerative Medicine (FIRM)

How to Apply

Please provide the required information in the application form below.

Appliction deadline

Friday, October 16. 2026 23:59

Contact us

JETRO Investment and Alliance Division, Innovation Department (in charge: Saito, Ishizuna, Ono)
E-mail: ive@jetro.go.jp Tel: 03-3582-5644

Is Japan Your Next Life Sciences Growth Market?

Open the transcript

Contact Us

Investing in and collaborating with Japan

We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.

Inquiry Form

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

Worldwide Offices